← Back to Search
Oxidative Modification Of Peroxiredoxin Is Associated With Drug-induced Apoptotic Signaling In Experimental Models Of Parkinson Disease*
Young Mook Lee, S. Park, Dong-ik Shin, Jee-Yeon Hwang, Bokyung Park, Yun-jong Park, T. Lee, H. Chae, B. Jin, T. Oh, Y. Oh
Published 2008 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
The aim of this study was to investigate changes in protein profiles during the early phase of dopaminergic neuronal death using two-dimensional gel electrophoresis in conjunction with mass spectrometry. Several protein spots were identified whose expression was significantly altered following treatment of MN9D dopaminergic neuronal cells with 6-hydroxydopamine (6-OHDA). In particular, we detected oxidative modification of thioredoxin-dependent peroxidases (peroxiredoxins; PRX) in treated MN9D cells. Oxidative modification of PRX induced by 6-OHDA was blocked in the presence of N-acetylcysteine, suggesting that reactive oxygen species (ROS) generated by 6-OHDA induce oxidation of PRX. These findings were confirmed in primary cultures of mesencephalic neurons and in rat brain injected stereotaxically. Overexpression of PRX1 in MN9D cells (MN9D/PRX1) exerted neuroprotective effects against death induced by 6-OHDA through scavenging of ROS. Consequently, generation of both superoxide anion and hydrogen peroxide following 6-OHDA treatment was decreased in MN9D/PRX1. Furthermore, overexpression of PRX1 protected cells against 6-OHDA-induced activation of p38 MAPK and subsequent activation of caspase-3. In contrast, 6-OHDA-induced apoptotic death signals were enhanced by RNA interference-targeted reduction of PRX1 in MN9D cells. Taken together, our data suggest that the redox state of PRX may be intimately involved in 6-OHDA-induced dopaminergic neuronal cell death and also provide a molecular mechanism by which PRX1 exerts a protective role in experimental models of Parkinson disease.
This paper references
Brain peroxidase and catalase in Parkinson disease.
L. Ambani (1975)
Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.
D. Graham (1978)
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
J. Bottenstein (1979)
The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5
Larry W. Swanson (1984)
Glutathione peroxidase activity in Parkinson's disease brain
S. Kish (1985)
Superoxide dismutase and Parkinson's disease
I. Ceballos (1990)
The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons
D. Ben-Shachar (1991)
Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion
Hyung K. Choi (1991)
Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions.
H. Choi (1992)
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
E. Sofić (1992)
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
S. Fahn (1992)
Rapid identification of proteins by peptide-mass fingerprinting
D. Pappin (1993)
Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae.
H. Z. Chae (1993)
Glutathione peroxidase, glial cells and Parkinson's disease
P. Damier (1993)
Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes.
H. Z. Chae (1994)
Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line
Y. Oh (1995)
The ubiquitin pathway in Parkinson's disease
E. Leroy (1998)
Increased Protein Oxidation in Human Substantia Nigra Pars Compacta in Comparison with Basal Ganglia and Prefrontal Cortex Measured with an Improved Dinitrophenylhydrazine Assay
E. Floor (1998)
The Rat Brain
G. Paxinos (1998)
Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic Neurons
Julie Lotharius (1999)
Two distinct mechanisms are involved in 6‐hydroxydopamine‐ and MPP+‐induced dopaminergic neuronal cell death: Role of caspases, ROS, and JNK
Won‐Seok Choi (1999)
Differential expression of peroxiredoxin subtypes in human brain cell types.
T. Sarafian (1999)
Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin.
H. Chae (1999)
Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation.
A. Claiborne (1999)
Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis.
Y. Zhou (2000)
Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system
H. Mizusawa (2000)
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
B. Giasson (2000)
Causes of neuronal death in Parkinson's disease.
A. Schapira (2001)
Augmented expression of peroxiredoxin I in lung cancer.
J. Chang (2001)
Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat
A. Mitsumoto (2001)
Proteomics Analysis of Cellular Response to Oxidative Stress
T. Rabilloud (2002)
An Antisense Oligonucleotide to 1-cys Peroxiredoxin Causes Lipid Peroxidation and Apoptosis in Lung Epithelial Cells*
J. Pak (2002)
Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein
J. Fujii (2002)
Inactivation of Human Peroxiredoxin I during Catalysis as the Result of the Oxidation of the Catalytic Site Cysteine to Cysteine-sulfinic Acid*
Kap-Seok Yang (2002)
Thrombin-Induced Microglial Activation Produces Degeneration of Nigral Dopaminergic Neurons In Vivo
Sang-H Choi (2003)
Caspase-Dependent and -Independent Cell Death Pathways in Primary Cultures of Mesencephalic Dopaminergic Neurons after Neurotoxin Treatment
B. Han (2003)
Structure, mechanism and regulation of peroxiredoxins.
Z. Wood (2003)
A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau
B. S. Han (2003)
Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways*
S. Allen (2003)
Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice.
F. Plaisant (2003)
Mitochondrial peroxiredoxin‐3 protects hippocampal neurons from excitotoxic injury in vivo
F. Hattori (2003)
ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin
B. Biteau (2003)
Parkinson's Disease Mechanisms and Models
W. Dauer (2003)
Reversing the Inactivation of Peroxiredoxins Caused by Cysteine Sulfinic Acid Formation
H. A. Woo (2003)
Reversible Oxidation of the Active Site Cysteine of Peroxiredoxins to Cysteine Sulfinic Acid
H. Woo (2003)
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
K. Krapfenbauer (2003)
Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is underexpressed in Down syndrome fetal brains
M. F. Sánchez-Font (2003)
Regeneration of Peroxiredoxins during Recovery after Oxidative Stress
M. Chevallet (2003)
F Plaisant (2003)
Phosphorylation of p38 MAPK Induced by Oxidative Stress Is Linked to Activation of Both Caspase-8- and -9-mediated Apoptotic Pathways in Dopaminergic Neurons*
Wonseok Choi (2004)
Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis.
Christoph W. Strey (2004)
Overexpression of antioxidant enzyme peroxiredoxin 5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress.
J. Yuan (2004)
Cytosolic Peroxiredoxin Attenuates The Activation Of Jnk And P38 But Potentiates That Of Erk In Hela Cells Stimulated With Tumor Necrosis Factor-α*
S. W. Kang (2004)
Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases*
Joungil Choi (2004)
A 2-Cys peroxiredoxin regulates peroxide-induced oxidation and activation of a stress-activated MAP kinase.
E. Veal (2004)
Molecular pathophysiology of Parkinson's disease.
D. Moore (2005)
Oxidation of a Eukaryotic 2-Cys Peroxiredoxin Is a Molecular Switch Controlling the Transcriptional Response to Increasing Levels of Hydrogen Peroxide*
Stephanie M. Bozonet (2005)
Dopamine covalently modifies and functionally inactivates parkin
M. Lavoie (2005)
Sulfiredoxin: a potential therapeutic agent?
V. Findlay (2005)
Redox control of catalytic activities of membrane-associated protein tyrosine kinases.
I. Nakashima (2005)
The thioredoxin system in retroviral infection and apoptosis
H. Masutani (2005)
Oxidative Modifications and Aggregation of Cu,Zn-Superoxide Dismutase Associated with Alzheimer and Parkinson Diseases*
Joungil Choi (2005)
Mitochondria, Oxidants, and Aging
R. Balaban (2005)
PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells.
Z. Liu (2005)
Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling.
S. Rhee (2005)
Characterization of neural cell types expressing peroxiredoxins in mouse brain
Mei-hua Jin (2005)
S G Rhee (2005)
Dual Role of Peroxiredoxin I in Macrophage-derived Foam Cells*
J. P. Conway (2006)
Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex.
Yun-Jeong Kim (2006)
Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases*
Joungil Choi (2006)
Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action.
Yoshiro Saito (2007)
Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection
H. Masutani (2007)
Does thioredoxin-1 prevent mitochondria- and endoplasmic reticulum-mediated neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine?
J. Bai (2007)
Role of Cdk5-Mediated Phosphorylation of Prx2 in MPTP Toxicity and Parkinson's Disease
Dianbo Qu (2007)
Y Saito (2007)
This paper is referenced by
Identification of Targets from LRRK2 Rescue Phenotypes
Joanne Toh (2021)
Proteomic Complexity in Parkinson’s Disease: A Redox Signaling Perspective of the Pathophysiology and Progression
M. Martinez-Banaclocha (2021)
Dysregulated autophagy is linked to BAX oligomerization and subsequent cytochrome c release in 6-hydroxydopmaine-treated neuronal cells.
Yuhyun Chung (2021)
Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson’s Disease
F. Teixeira (2020)
Peroxiredoxins in Neurodegenerative Diseases
M. Szeliga (2020)
Protective effect of hydrogen sulfide is mediated by negative regulation of epigenetic histone acetylation in Parkinson’s disease
Yang Sun (2020)
RING-finger protein 166 plays a novel pro-apoptotic role in neurotoxin-induced neurodegeneration via ubiquitination of XIAP
Chang-Ki Oh (2020)
α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo
Victor S. Van Laar (2020)
Chetomin rescues pathogenic phenotype of LRRK2 mutation in drosophila
L. Chua (2020)
Anamorsin attenuates cupric chloride-induced dopaminergic neuronal cell death.
Kyung-Ah Park (2019)
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder
P. Abruzzo (2019)
The neural stem cell secretome and its role in brain repair
Cory M Willis (2019)
Autophagy Stimulation Decreases Dopaminergic Neuronal Death Mediated by Oxidative Stress
Marcela J. Ramirez-Moreno (2019)
DNA Methylation Profiling in a Neuroblastoma Cell Line Exposed to the Antipsychotic Perospirone.
Y. Murata (2019)
Peroxiredoxin 5 Silencing Sensitizes Dopaminergic Neuronal Cells to Rotenone via DNA Damage-Triggered ATM/p53/PUMA Signaling-Mediated Apoptosis
Mei-Jen Wang (2019)
Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease
B. Mendes-Pinheiro (2018)
Dysregulated autophagy contributes to caspase-dependent neuronal apoptosis
Yuhyun Chung (2018)
Title Thiol redox homeostasis in neurodegenerative disease
G. McBean (2018)
Metabolic Disorder Dysfunction in Parkinson ’ s Disease : Bioenergetics , Redox Homeostasis and Central Carbon Metabolism
A. Anandhan (2017)
Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism
A. Anandhan (2017)
Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer’s Disease
L.E. Henderson (2017)
Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases
M. H. Park (2016)
Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells, Adipose Tissue-Derived Stem Cells, and Human Umbilical Cord Perivascular Cells: A Proteomic Analysis
O. PiresAna (2016)
Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells, Adipose Tissue-Derived Stem Cells, and Human Umbilical Cord Perivascular Cells: A Proteomic Analysis.
A. O. Pires (2016)
Thiol redox homeostasis in neurodegenerative disease
G. McBean (2015)
Luteolin-induced protection of H₂O₂-induced apoptosis in PC12 cells and the associated pathway.
P. Lin (2015)
Peroxiredoxin 1 suppresses apoptosis via regulation of the apoptosis signal-regulating kinase 1 signaling pathway in human oral leukoplakia.
M. Zhang (2015)
Amide-type adduct of dopamine - plausible cause of Parkinson diseases.
X. Liu (2014)
Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment
Dong-ik Shin (2014)
2-Cys Peroxiredoxins: Emerging Hubs Determining Redox Dependency of Mammalian Signaling Networks
J. Park (2014)
Morphine protects SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cell damage: involvement of anti-oxidant, calcium blocking, and anti-apoptotic properties.
L. Elyasi (2014)
Curcumin: A Potent Modulator of Multiple Enzymes in Multiple Cancers.
A. Shehzad (2014)See more